Related Experiment Video
Updated: Jan 29, 2026

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Predictive Value of Apelin-36 for No-Reflow Phenomenon in STEMI Patients
Xhevdet Krasniqi1,2, Xhevat Jakupi1, Josip Vincelj3
1Department of Internal Medicine, Medical Faculty, University of Prishtina "Hasan Prishtina", 10000 Prishtina, Kosovo.
Serum apelin-36 levels are associated with the no-reflow phenomenon in ST-segment elevation myocardial infarction (STEMI) patients. A cut-off value of 0.58 ng/mL can identify patients at increased risk of no-reflow after primary percutaneous coronary intervention.
Area of Science:
- Cardiology
- Biochemistry
- Medical Diagnostics
Background:
- Apelin is upregulated in ST-segment elevation myocardial infarction (STEMI) and offers cardioprotection against ischemia-reperfusion injury (IRI).
- Investigating serum apelin-36 levels in STEMI patients is crucial for understanding its role in the no-reflow phenomenon.
Purpose of the Study:
- To examine serum apelin-36 levels in STEMI patients.
- To determine the relationship between serum apelin-36 levels and the incidence of the no-reflow phenomenon post-primary percutaneous coronary intervention (pPCI).
Main Methods:
- 161 STEMI patients undergoing pPCI within 12 hours of symptom onset were enrolled.
- Serum apelin-36, troponin T, and other biochemical markers were measured.
- Echocardiography was performed, and patients were grouped based on apelin-36 levels.
Main Results:
- A higher incidence of no-reflow phenomenon was observed in patients with apelin-36 levels > 0.58 ng/mL (47.82%) compared to those with levels ≤ 0.58 ng/mL (25.21%).
- A positive correlation was found between apelin-36 levels and the Gensini score.
- Apelin-36 and diabetes mellitus were identified as significant predictors of no-reflow, with a diagnostic cut-off value of 0.58 ng/mL (AUC = 0.77).
Conclusions:
- Serum apelin-36 levels are significantly associated with the no-reflow phenomenon in STEMI patients.
- An admission apelin-36 cut-off value of 0.58 ng/mL can aid in identifying STEMI patients at higher risk for no-reflow/reperfusion injury.
More Related Videos
Related Concept Videos
Tip-of-the-Tongue Phenomenon
Predicting Molecular Geometry
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
End Point Prediction: Gran Plot
For potentiometric titration, the Gran plot is created by plotting...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Predicting Reaction Outcomes

